Professor John Gribben

MD DSc FRCPath FRCP FMedSci
GMC: 2548364
5.02 reviewsReview
Book

Professional statement

Professor John Gribben is a leading haematologist based in London. He currently sees patients at London Haematology which is based at The London Clinic. He specialises in haematological cancers including lymphomas, leukaemias and bone marrow transplantation.


Professor Gribben graduated from the University of Glasgow in 1980. He also trained in haematology at University College London and in medical oncology at the Dana-Farber Cancer Institute, Harvard Medical School. Professor Gribben remained on the faculty for 17 years before returning to the UK.


He has written over 300 articles and chapters in peer-reviewed publications and is renowned for his new drugs and forms of cancer treatment. He has grant funding from The National Cancer Institute and Cancer Research UK for pioneering studies in lymphoma and leukaemia. He has sat on and chaired numerous international executive committees dedicated to investigating new methods of cancer care and many editorial boards for professional publications which are focused on cancer.


He has lectured across the world on new therapies for cancer treatment. In addition to his lectures, Professor Gribben has published more than 300 chapters and articles in peer-reviewed publications. He has also sat on and chaired several of the editorial boards for professional publications focused on cancer. 

Clinics

  • London Haemotology Clinic
  • The London Clinic

Credentials

Professional experience

  • 45 years of experience
  • Professor and Consultant Medical Oncologist, Barts and The London NHS Trust (present)
View more

Subspecialties

  • B-cell-tumour antigens
  • Detection and treatment of minimal residual disease
View more

Education

  • DSc, Glasgow (2002)
  • MD, Glasgow (1990)
View more

Publications and conferences

  • MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial. Pott C, Sehn LH, Belada D et al. Leukemia (2020) 34(2) 522-532
  • IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution. Odabashian M, Carlotti E, Araf S et al. Blood (2020) (2)
View more

Languages spoken

  • English
Registration number: 2548364

Content

Reviews

All reviews are from real patients and have been verified by our Customer Service department to ensure they meet our guidelines. Rules of the service

2 reviews

5.0

Review this doctor
  • Would you recommend this doctor?
  • Treatment of the doctor
  • Treatment of the staff
  • Waiting time
  • Condition of facilities
  • Prof, John Gribbens is obviously an expert in his field, but when choosing between him & another excellent hematologist, it was his direct, kind, measured and honest approach which set him apart. His easy nature dealing with something so serious was brilliant. he also cured me!
    28 October 2024

    C.C.

    Verified patient
  • Every year, I have the privilege of meeting with Professor Gribben to assess my bloodwork. Without fail, he exhibits the utmost humanity and humility, making each encounter a deeply comforting and empathetic experience.
    30 January 2024

    M.P.

    Verified patient

Treatments

Frequently Asked Questions

The doctor, or where applicable the hospital or medical centre in which the doctor provides services, undertakes to keep the information relating to the prices of services published on their profile on the Top Doctors platform up to date at all times, ensuring that such prices correspond to those effectively charged to patients. In the event of any discrepancy between the published price and the price ultimately charged to the patient, the doctor and/or the relevant hospital or medical centre shall be solely liable towards the patient and towards Top Doctors for any claim or financial difference arising therefrom.